VKTX
VIKING THERAPEUTICS INCData as of 2026 Q2 (06-30) · 13F snapshot
Summary
VIKING THERAPEUTICS INC (VKTX) is held as common stock by 6 tracked hedge-fund managers, with a combined reported value of ~$95.14M; the largest are Ken Griffin, Izzy Englander, Steven Cohen. 4 tracked managers also disclosed PUT or CALL positions, reported separately below. This quarter: 1 new, 3 added, 2 trimmed. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.
Attention · MediumThis quarter · Heating up
Common-stock holders64 also report options
Congress trades0
Price$33.03vs quarter-end-15.33%
Sectors1
This quarter's moves
Top holderNew1
Added3
Trimmed / sold2
Ken GriffinCommon-stock positions
PUT and CALL disclosures are excluded from these holder counts and values.
| Investor | Value | % of portfolio | Action |
|---|
PUT / CALL disclosures
Reported separately: 13F option values are not common-stock ownership and do not reveal the full strategy or economic exposure.
Value $43.77M— of portfolio1,122,1002026 Q2
Value $23.53M— of portfolio603,2002026 Q2
Value $3.51M— of portfolio90,0002026 Q2
Value $987.0K— of portfolio25,3002026 Q2
Value $651.5K— of portfolio16,7002026 Q2
Value $390.1K— of portfolio10,0002026 Q2
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Ken GriffinCALL | $43.77M | — | — |
| Ken GriffinPUT | $23.53M | — | — |
| Paul Tudor JonesCALL | $3.51M | — | — |
| Steven CohenCALL | $987.0K | — | — |
| Izzy EnglanderCALL | $651.5K | — | — |
| Steven CohenPUT | $390.1K | — | — |
Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.